#+TITLE: Fasting Urine Organic Acids
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
# #+BEAMER_THEME: Ilmenau [height=20pt]
# #+BEAMER_THEME: Szeged  [height=20pt]
#+BEAMER_THEME: Boadilla [height=20pt]
#+BEAMER_COLOR_THEME: [RGB={170,160,80}]{structure}
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Document subtitle}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=gray,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
# #+LaTeX_HEADER: \AtBeginSection[]{\begin{frame}\tableofcontents[currentsection] \end{frame}}
:END:

#+BEGIN_LaTeX
\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}


\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]


#+END_LaTeX

* Background
** Critical Sample
- Abnormal urinary organic acid profiles of patients with FAOD may
  occur only during acute episodes of hypoglycemia and/or fasting.

  - plasma concentration of fatty acids increases, leading to an
    elevated urinary excretion of medium-chain dicarboxylic acids.

- Clinical notes refer to "Ketotic Hypoglycemia"

- These medium-chain saturated metabolites usually include adipic
  (DC6), suberic (DC8), and sebacic (DC10) acids?

** Fasting Urine Organic Acids
- Many samples are sent from the ED or ICU in cases of prolonged
  fasting, vomiting, dehydration.

- Urine organic acid results include:
  - lactate
  - urea
  - ketones
  - BCAA intermediate metabolites
  - dicarboxylic acids
  - NSAIDs


** Clinical History 

- a 5 yo female who had come to the ED twice in the last year with
  vomiting, dehydration and hypoglycemia.

- urine organic acids elevation in alpha-ketoacids 
  - 2-ketoisocaproic
  - 2-ketoisovaleric
  - 2-keto-3-methylvaleric
  - urine creatinine = 4,113 umol/L

- Plasma amino acids performed on a sample drawn at the same time
  revealed a small elevation in BCAAs:
  - Val = 608
  - Ile = 293
  - Leu = 484
  - Allo-Ile = 7

- All amino acids and organic acids were normal in the convalescent
  sample.

- *Ketotic dicarboxylic aciduria*

** Fasting Profile
[[./figures/fasting_rotate.png]]

** Convalescent Profile
[[./figures/convalescent_rotate.png]]

** Glucose Sources with Fasting
[[./figures/fasting_graph1.pdf]]

\tiny
courtesy of SIMD-NAMA

*** COMMENT
Postprandially as glucose absorption declines and glucagon
concentrations rise, insulin concentrations drop; this removes
inhibition on adipose tissue lipoprotein lipase resulting in free
fatty acid release. Many tissues preferentially oxidise fatty
acid. The brain requires glucose but can adapt over days to use
ketones as an oxidative substrate. Glycogenolysis and gluconeogenesis
maintain glucose concentrations. Thus homoeostasis involves
coordination of multiple metabolic and endocrine pathways.

** Energy Sources with Fasting

[[./figures/fasting_graph2.pdf]]

\tiny
courtesy of SIMD-NAMA

** Ketonuria

[[./figures/ketones.png]]

- Ketone bodies
  - \beta-hydroxybutyric acid
  - acetoacetic acid


** Ketotic Hypoglycemia does not rule out an IMD

- Other conditions which can present with ketotic hypoglycaemia are:
  - FAOD: VLCADD, MCADD 
    - inappropriately low ketones
- intermediate form of MSUD
- organic acidaemia: methylmalonic and isovaleric acidaemia
- multiple carboxylase deficiency
- defects of gluconeogenesis,
  - such as glycogen storage disease type 1a

**  Dicarboxylic Aciduria

*** Ketotic Dicarboxylic Aciduria.
- Physiological response to hypoglycemia
  - DC6 > DC8 > DC10 

*** Non-Ketotic Dicarboxylic Aciduria.
- FAOD:
  - DC6 > DC8 > DC10 
- MCAD + MCT
  - DC10 > DC8 > DC6
  - or DC8 > DC10 > DC6 in some cases.

- All fatty acid oxidation defects will permit production of ketones.

** BCAA metabolites
\centering
#+ATTR_LATEX: :height 0.85\textheight
[[./figures/bcaa.png]]

** Dehydration
- Urine Creatinine > 4,000 umol/L

- 3-hydroxypropionic - PA
- 3-hydroxyisovaleric - IVA
- 3-methylglutaconic - 3-methylglutaconic aciduria



